Selina Zhang

Selina Zhang has a diverse and extensive work experience. Selina is currently the Global Clinical Study Director at BeiGene, a position they have held since January 2023. Prior to that, they served as the Executive Director and head of Clinical Operations for Oncology at "Sanyao Medicinal Plant Pharmaceutical" from October 2021 to January 2023. Selina also worked at "Luo Co., Ltd." as a Global Studies Leader from September 2017 to October 2021, and at AstraZeneca as a Clinical Development Manager from June 2012 to September 2017. Selina began their career at Eisai China Inc. as a Senior Clinical Project Supervisor from September 2010 to May 2012. Selina also has experience as a Project Manager at "Shanghai Huashan Pharmaceutical Limited Company" from November 2006 to September 2010 and as an Assistant to Director at the Chinese Academy of Science, Shanghai Institute for Advanced Science from June 2005 to October 2006.

Selina Zhang earned a Bachelor of Science in Pharmaceutical Engineering from Nanjing University from 1998 to 2002. Selina then went on to complete a Master of Science in Biochemistry and Molecular Biology at the Chinese Academy of Sciences from 2002 to 2005.